This podcast episode, sponsored by Leo Pharma, features LiVDerm faculty and esteemed dermatologists Dr. Christopher Bunick, MD, PhD, and Dr. Jonathan Silverberg, MD, PhD, MPH. As experts in all things concerning eczema, our faculty discuss the differentiating features and disease burden in patients suffering from chronic hand eczema (CHE) and review the current guidance for treatment, including these specific topics:

1. Differentiating CHE from atopic dermatitis of the hands, including triggers, pathophysiology, and clinical presentation
2. Expert guidance for accurate diagnosis and work-up of CHE patients
3. Challenges and limitations of current therapeutic offerings
4. The potential of a topical novel pan-JAK inhibitor for targeted treatment of CHE